Low-molecular-weight EGFR/KDR tyrosine kinase inhibitor offers combinatorial benefit with a rapamycin derivative based on PTEN status
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Rich, J; Shi, Q; Hjelmeland, M; Goudar, R; Keir, S; McLendon, R; Reese, E; Traxler, P; Lane, H; Bigner, D; Friedman, H
Published Date
- July 1, 2005
Published In
Volume / Issue
- 7 / 3
Start / End Page
- 343 - 344
Published By
Pages
- 2
International Standard Serial Number (ISSN)
- 1522-8517
Conference Name
- 2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Conference Location
- Edinburgh, SCOTLAND
Conference Start Date
- May 5, 2005
Conference End Date
- May 8, 2005